Cohen & Steers Inc (CNS)
Official siteFINANCIAL SERVICES • ASSET MANAGEMENT • NYSE
Market Cap: $3.60B
Last updated: Nov 17, 2026 at 4:10 PM ET
Cohen & Steers Inc (CNS) Statistics
Cohen & Steers (CNS) has a market cap of $3.60B and an enterprise value of $3.54B. Its return on invested capital of 24.81% compares with a 5.26% median across 8 similar companies.
Total Valuation
Enterprise value is 1.66% below the market cap, as cash exceeds debt.
| Market Cap | $3.60B |
|---|---|
| Enterprise Value | $3.54B |
| Latest price (Nov 17, 2026) | $68.36 |
Key Dates
The next earnings report is expected on Jan 20, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 9, 2026.
| Next Earnings Date | Jan 20, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 15, 2026 |
| Last Ex-Dividend Date | Nov 9, 2026 |
| Next Payment Date | Nov 19, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.8x and 5.8x. Its year-end P/E ranged from 14.2x to 31.5x from 2016 to 2025.
| P/E Ratio | 20.5x |
|---|---|
| Forward P/E | 19.6x |
| P/S Ratio | 5.8x |
| Forward P/S | 5.9x |
| P/B Ratio | 5.8x |
| P/TBV Ratio | 6.0x |
| P/FCF Ratio | 99.2x |
| P/OCF Ratio | 94.8x |
| PEG Ratio | 2.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 15.8x EBITDA and 97.5x free cash flow.
| EV / Earnings | 21.0x |
|---|---|
| EV / Sales | 5.8x |
| EV / EBITDA | 15.8x |
| EV / FCF | 97.5x |
Price Statistics
The stock is up 7.65% over 52 weeks and trades 4.74% below its 50-day average.
| Beta (1Y) | 0.61 |
|---|---|
| 52-Week Change | +7.65% |
| 1-Month Change | +0.83% |
| 3-Month Change | -15.03% |
| 6-Month Change | -3.89% |
| 5-Year Change | -23.62% |
| 10-Year Change | +94.94% |
| Total Return (1Y) | +11.87% |
| Total Return (3Y CAGR) | +8.36% |
| Total Return (5Y CAGR) | -4.49% |
| Return vs SPY (1Y) | +6.12% |
| Max Drawdown (1Y) | -22.49% |
| Max Drawdown (3Y) | -42.60% |
| Sharpe Ratio (1Y) | 0.61 |
| Correlation with SPY (1Y) | 0.32 |
| 50-Day Average | $71.76 |
| 200-Day Average | $71.48 |
| 52-Week Range | $56.28 to $85.77 |
| RSI (14 Days) | 39.9 |
| Average Volume (20 Days) | 248.21K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 0.01x shareholder equity.
| Debt / Equity | 0.01x |
|---|---|
| Debt / EBITDA | 0.03x |
| Debt / FCF | 0.18x |
Returns and Efficiency
Return on invested capital is 24.81% over the last 12 months, against a 5-year average of 28.97%.
| Return on Equity (ROE) | 27.70% |
|---|---|
| Return on Assets (ROA) | 17.18% |
| Return on Invested Capital (ROIC) | 24.81% |
| ROE (5Y Average) | 45.71% |
| ROA (5Y Average) | 24.93% |
| ROIC (5Y Average) | 28.97% |
| Asset Turnover | 0.69x |
Taxes
Income tax took 26.01% of pretax income over the last 12 months.
| Income Tax (TTM) | $59.18M |
|---|---|
| Effective Tax Rate | 26.01% |
Scores
CNS has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue of $611.23M over the last 12 months is up 8.82% from the 12 months before.
| Revenue | $611.23M |
|---|---|
| Revenue Growth (YoY) | +8.82% |
| Pretax Income | $227.50M |
| Net Income | $168.32M |
| Reported EPS (TTM) | $3.34 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 62.02% of the $979.82M in total assets.
| Cash and Equivalents | $66.12M |
|---|---|
| Total Debt | $6.39M |
| Net Cash | $59.73M |
| Net Cash Per Share | $1.16 |
| Shareholder Equity | $607.68M |
| Book Value Per Share | $11.78 |
| Tangible Book Value | $588.00M |
| Tangible Book Per Share | $11.40 |
| Total Assets | $979.82M |
| Total Liabilities | $231.09M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.40M of capital spending, operating cash flow left $35.55M of free cash flow.
| Operating Cash Flow | $37.94M |
|---|---|
| Capital Expenditures | $2.40M |
| Free Cash Flow | $35.55M |
| FCF Per Share | $0.69 |
| Depreciation and Amortization | $13.01M |
| Dividends Paid | $135.35M |
| Share Repurchases | $19.23M |
Trailing 12 months through Sep 30, 2026.
Margins
| Pretax Margin | 37.22% |
|---|---|
| Net Margin | 27.54% |
| FCF Margin | 5.82% |
| Gross Margin (5Y Average) | 50.94% |
| Operating Margin (5Y Average) | 36.04% |
| Net Margin (5Y Average) | 30.23% |
Growth
Revenue grew 1.40% a year over 3 years, and EPS fell 5.81% a year.
| Revenue Growth (3Y CAGR) | +1.40% |
|---|---|
| Revenue Growth (5Y CAGR) | +5.93% |
| EPS Growth (3Y CAGR) | -5.81% |
| EPS Growth (5Y CAGR) | +3.74% |
| Operating Income Growth (3Y CAGR) | -6.28% |
| Book Value Per Share Growth (2Y CAGR) | +19.14% |
| Tangible Book Per Share Growth (2Y CAGR) | +20.09% |
Dividends and Yields
CNS pays out 82.10% of earnings as dividends.
| Dividend Per Share (Annual) | $2.68 |
|---|---|
| Dividend Yield | 3.92% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +4.07% |
| Dividend Growth (5Y CAGR) | +16.21% |
| Payout Ratio | 82.10% |
| FCF Payout Ratio | 380.78% |
| Earnings Yield | 4.88% |
| FCF Yield | 1.01% |
| Buyback Yield | 0.51% |
| Shareholder Yield | 4.35% |
Peer Position
Against 11 similar companies, CNS has the 2nd highest P/E and the 7th highest P/S.
P/E RatioPeer median 9.2x
P/S RatioPeer median 6.0x
ROICPeer median 5.26%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.65%
Dividend YieldPeer median 7.10%
| P/E Ratio | 20.5x vs 9.2x median |
|---|---|
| P/S Ratio | 5.8x vs 6.0x median |
| ROIC | 24.81% vs 5.26% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +8.82% vs +3.65% median |
| Dividend Yield | 3.92% vs 7.10% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.83% and EPS growth at 9.35% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.83% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +9.35% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CNS
What is CNS's market cap?
Cohen & Steers has a market cap of $3.60B. Its enterprise value, which adds debt and subtracts cash, is $3.54B.
What is CNS's P/E ratio?
Cohen & Steers has a trailing P/E ratio of 20.5x and a forward P/E of 19.6x.
How many shares of CNS are outstanding?
Cohen & Steers has 51.57M shares outstanding. The count is up 0.71% from a year earlier.
Does CNS pay a dividend?
Yes. Cohen & Steers pays $2.68 a share a year, a dividend yield of 3.92%.
How much debt does CNS have?
Cohen & Steers has $6.39M of total debt and $66.12M of cash and equivalents, a net cash position of $59.73M.
CNS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors